Cardima's Naviport
This article was originally published in The Gray Sheet
Executive Summary
Deflectable-tip guiding catheter for the delivery of therapeutic microcatheters into the chambers or vasculature of the heart receives CE mark approval, the firm says March 4. FDA clearance for the device is expected in the first half of this year. The Fremont, California-based firm also says that it has received FDA's permission to expand from 15 patients to 30 an ongoing clinical trial of the Revelation Tx microcatheter for atrial fibrillation